/RACA
RACA Stock - Therapeutics Acquisition Corp.
Financial Services|Shell CompaniesNASDAQ
$10.27+2.44%
+$0.24 (+2.44%) • Jul 1
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.31
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $11.30
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RACA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$10.17 – $10.38
TARGET (TP)$11.82
STOP LOSS$9.45
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$18.08
52W Low$9.81
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RACALoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about RACA
What is RACA's current stock price?
Therapeutics Acquisition Corp. (RACA) is currently trading at $10.27 per share. The stock has moved +2.44% today.
What is the analyst price target for RACA?
No analyst price targets are currently available for this stock.
What sector is Therapeutics Acquisition Corp. in?
Therapeutics Acquisition Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.
What is RACA's market cap?
Therapeutics Acquisition Corp. has a market capitalization of $1.09 billion, making it a small-cap company.
Does RACA pay dividends?
No, Therapeutics Acquisition Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAMHC
Amplitude Healthcare Acquisition Corporation
$10.23
Mkt Cap: $1.1B
DNAA
Social Capital Suvretta Holdings Corp. I
$14.07
Mkt Cap: $1.1B
FGNA
FG New America Acquisition Corp.
$9.97
Mkt Cap: $1.1B
HERA
FTAC Hera Acquisition Corp.
$10.19
Mkt Cap: $1.1B
HUMA
Humacyte, Inc.
$1.11
Mkt Cap: $0.2B
LSAQ
LifeSci Acquisition II Corp.
$9.01
Mkt Cap: $1.1B
PACE
TPG Pace Tech Opportunities Corp.
$11.20
Mkt Cap: $1.1B
TREB
Trebia Acquisition Corp.
$9.45
Mkt Cap: $1.1B
Explore stocks similar to RACA for comparison